A startup incubated in the Indian Institute of Science (IISc), Bengaluru, is developing a Covid-19 Vaccine that can be stored at 37 degrees Celsius, a development that could be a game-changer for India which lacks sufficient cold chain facilities.
“All (Covid) Vaccine candidates in clinical trials currently require refrigerated temperatures of at least four degrees. Ours would not, in principle,” biophysicist Raghavan Varadarajan, who heads the startup Mynvax, told DH.
“For Covid-19, no one has shown equivalent data of the temperature. They have exposed it to much higher temperatures than 37 degrees for shorter periods of time, and it was okay.” This heat-tolerant medicine can also withstand the heat of 70C for about 16 hours. In comparison, the front runner, AstraZeneca-Oxford’s Covishield Vaccine, manufactured by Pune’s Serum Institute, will have to be refrigerated at 2-8 degrees.
Read more at:
Random Posts
Dipika, Sita of 1980s TV serial RAMAYAN, is a still popular on social mediaMay 23, 2022- Every third kid in Karnataka under-nourishedMay 15, 2022
- Slippery Carpet or Tight Rope Walk?May 15, 2022
- Marie Curie … Major ContributionsMay 15, 2022
- Maldives President issues decree to ban ‘anti-India-protests’May 15, 2022
Forum Topics
-
By Swati Aiyer, 2 years ago
-
SC Grants Interim Bail to Arnab Goswami
By Navneet Bakshi, 2 years ago
-
By Navneet Bakshi, 2 years ago
Thewriterfriends.com is an experiment to bring the creative people together on one platform. It is a free platform for creativity. While there are hundreds, perhaps thousands of platforms that provide space for expression around the world, the feeling of being a part of fraternity is often lacking. If you have a creative urge, then this is the right place for you. You are welcome here to be one of us.
Random Posts
Good if they are doing it, but first it is the vaccine that is urgently required.
Yes. They are developing the vaccine. Vaccine likely to be available commercially by mid 2022 provided they get the funding and approval for human trials mentioned in blog.
Varadarajan’s team has carried out extensive animal testing in mice and guinea pigs with promising results. Challenging studies in hamsters are in progress, with the animal trials expected to be completed by December. It is still a long way to test on humans. Currently the startup is canvassing for funds to that.
Read more at: https://www.deccanherald.com/city/top-bengaluru-stories/bengaluru-startup-developing-heat-tolerant-covid-19-vaccine-912410.html?fbclid=IwAR3oICThiy7wqMUB2OP34fQqxTib7SLgVRZXUDLiSmX5ORLvaGkQKaP_AAE